Lidocaine Hci And Epinephrine With Epinephrine Injection, Solution
Product Images NDC 51662-1412

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci And Epinephrine With Epinephrine (NDC 51662-1412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662 141 23 Case Label

Label for XYLOCAINE-MPF (Lidocaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000, 2%, 20 mg/10 mL (20 mg/mL) 10 mL vial, packaged 25 per box. NDC 51662-1412-3, lot 123456, expiration 2030-01-01. Manufactured by HF Acquisition Co., LLC in Mukilteo, WA 98275. The label lists components per mL, storage instructions, and usage routes including infiltration, nerve block, caudal, and epidural.*

FDA Label Image

51662 1412 2 Pouch Label

Label for XYLOCAINE®-MPF injection, containing lidocaine HCl and epinephrine at 20 mg/mL and 0.0002%. The label indicates the vial size as 10 mL and specifies use for infiltration and nerve block, including caudal and epidural. Manufactured by HF Acquisition Co., LLC, with NDC 51662-1412-2. The label includes lot number, expiration date, storage instructions, and cautions about drug appearance and handling.*

FDA Label Image

51662 1412 3 Rfid Hf Label

A white rectangular label on packaging for LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE injection solution. The label includes a GS1 DataMatrix barcode and multiple numeric codes, along with distributor information: HF Acquisition Co., LLC, Mukilteo, WA 98275. The label states 'See manufacturer’s package insert' and 'RX ONLY' vertically on the right side.*

FDA Label Image

How Supplied 1 (How Supplied 1)

This table lists multiple NDC codes for various strength and package size options of a medication presented in 10 mL, 20 mL, and 50 mL multiple dose vials. It details the product codes, unit sales, corresponding NDC numbers, strength percentages, and dosage strengths in mg per mL and total mg per container volume.*

FDA Label Image

How Supplied 2 (How Supplied 2)

A data table listing product codes, units of sale, strength, and packaging details for various dosages of a medication. It includes NDC codes for different vial and ampule sizes with specified strengths, such as 0.5%, 1% solutions in volumes from 2 mL to 50 mL. The table organizes dosage forms as single-dose vials and plastic ampules with concentrations and corresponding milligrams per milliliter.*

FDA Label Image

How Supplied 3 (How Supplied 3)

A data table listing product codes, unit of sale, strength, and package information for multiple drug products. It details strengths in percentages and mg per mL, units of 25 vials, and vial sizes from 10 mL to 50 mL multiple dose vials for various NDC codes.*

FDA Label Image

How Supplied 4 (How Supplied 4)

A data table presenting product information for a drug, including code, unit of sale, strength, and packaging details. It lists an NDC 63323-481-57 with a 0.50% strength (250 mg per 50 mL or 5 mg per mL) and packaging as a 50 mL multiple dose vial, unit of 25.*

FDA Label Image

How Supplied 5 (How Supplied 5)

A data table listing product codes, units of sale, strengths, and packaging details for multiple strengths and vial sizes of a medication. Strengths range from 1% to 2%, with vial sizes from 10 mL to 30 mL single dose vials and units of 5 or 25. The table details NDC codes specific to each packaging and strength.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

Maximum Recommended Dosages (Maximum Recommended Dosages)

A dose recommendation table for Xylocaine (lidocaine hydrochloride) injection without epinephrine, showing concentration percentages, volume in milliliters, and total dose in milligrams for various procedures including infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks such as epidural, anesthesia, and surgical anesthesia.*

FDA Label Image

Precautions (Precautions)

A table listing drug classes and examples of drugs within each class. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with specific drug names provided as examples under each category.*

FDA Label Image

Structure 1 (Structure 1)

Chemical structure diagram of lidocaine hydrochloride, showing its molecular components and arrangement including aromatic ring, ethyl groups, and hydrochloride (HCl) component.*

FDA Label Image

Structure 2 (Structure 2)

Chemical structure diagram of epinephrine, one of the active ingredients in Lidocaine HCI and Epinephrine injection solution, showing its molecular arrangement with hydroxyl groups and amine functional group.*

FDA Label Image

Serialized Vial Labeling (Seialized Vial Labeling)

This image shows a glass vial of Xylocaine-MPF (lidocaine HCl and epinephrine injection, USP) with Epinephrine 1:200,000, 2% strength, containing 200 mg per 10 mL (20 mg per mL). It is a 10 mL single dose vial labeled for infiltration and nerve block use, including caudal and epidural routes. The vial has a red cap and the label states it is methylparaben free, distributed by HF Acquisition Co., LLC.*

FDA Label Image

Vial 1 (Vial 1)

Xylocaine-MPF (lidocaine HCl and epinephrine injection, USP) 2% solution with epinephrine 1:200,000, 200 mg per 10 mL (20 mg per mL) in a 10 mL single dose vial. The label indicates use for infiltration and nerve block, including caudal and epidural use. The vial has a red cap and is marked for prescription use only.*

FDA Label Image

Vial 2 (Vial 2)

Close-up image of a vial label for Lidocaine HCl and Epinephrine injection solution. The label includes storage instructions, cautioning against autoclaving and advising protection from light and temperature control between 20° to 25°C. The vial features a red cap and is labeled by Fresenius Kabi, Lake Zurich, IL, with a website provided.*

FDA Label Image

Vial 3 (Vial 3)

LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE injection solution in a clear glass vial with a red plastic cap on a gray metal seal. The vial display includes a white label showing the lot number and expiration date (EXP 06/21), as well as a barcode. The product is labeled by HF Acquisition Co LLC, DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.